TWD
ADMA icon

True Wealth Design’s ADMA Biologics ADMA Stock Holding History

True Wealth Design’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3K Buy
+394
New +$3.59K ﹤0.01% 1498
2025
Q4 		– Sell
-11
Closed -$162 – 2561
2025
Q3 		$162 Sell
11
-2
-15% -$34 ﹤0.01% 2352
2025
Q2 		$237 Sell
13
-14
-52% -$285 ﹤0.01% 2016
2025
Q1 		$536 Buy
27
+13
+93% +$225 ﹤0.01% 1518
2024
Q4 		$241 Sell
14
-287
-95% -$5.4K ﹤0.01% 1195
2024
Q3 		$6.02K Sell
301
-399
-57% -$6.21K ﹤0.01% 523
2024
Q2 		$7.83K Buy
+700
New +$5.87K ﹤0.01% 253

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

True Wealth Design's ADMA Position: Q2 2026 in Review

True Wealth Design opened a new position in ADMA Biologics (ADMA) in Q2 2026: 394 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #1498 among its holdings. This is a return to the name: True Wealth Design previously reported a position in ADMA as recently as Q3 2025.

True Wealth Design first reported a position in ADMA in Q2 2024 and has held it in 7 quarters since. The position peaked at $7.83K in Q2 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • True Wealth Design held 394 shares of ADMA Biologics worth $3.3K as of Q2 2026.
  • ADMA Biologics was a new True Wealth Design position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1498 holding.
  • True Wealth Design first reported a position in ADMA Biologics in Q2 2024 and has held it in 7 quarters since.
  • True Wealth Design's ADMA Biologics position peaked at $7.83K in Q2 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.